Loading

Balancing innovation in new modalities with neurotoxicity and safety concerns

05 May 2026

09:05 - 10:05

Novel Modalities

Industry Expert

Shyam Ramachandran, Executive Director of Genomic Medicines for Neurological and Immunological Diseases - Sanofi